Results 81 to 90 of about 2,011 (166)

Trypanosomatid parasites, translational research in a One Health, One World environment. [PDF]

Front Chem
Ponte-Sucre A.
europepmc   +1 more source

Eflornithine Hydrochloride Ointment [PDF]

, 2020
openaire   +1 more source

Transforming the chemotherapy of human African trypanosomiasis. [PDF]

Clin Microbiol Rev
Barrett MP.
europepmc   +1 more source

Eflornithine Hydrochloride [PDF]

, 2020
openaire   +1 more source

RNA Polymerase 1 inhibitors against African trypanosomes <i>in vitro</i> and in mice. [PDF]

Antimicrob Agents Chemother
Cumming AV, Nenortas NP, Nenortas E, Bakshi RP, Caton ER, Rios-Guzman E, Barry ME, Barrow JC, Laiho M, Shapiro TA.   +9 more
europepmc   +1 more source

Beyond the Razor: Managing Pseudofolliculitis Barbae in Skin of Color. [PDF]

Fed Pract
Welch D, Usatine RP, Heath CR.
europepmc   +1 more source

Familial adenomatous polyposis: non-surgical management of large bowel disease: endoscopic and chemoprevention strategies. [PDF]

Fam Cancer
Daca-Álvarez M, Latchford A, Pellisé M, Balaguer F.   +3 more
europepmc   +1 more source

New insights for an old drug: difluoromethylornithine boosts the trypanocidal action of benznidazole on <i>Trypanosoma cruzi in vitro</i> and <i>in vivo</i>. [PDF]

Front Cell Infect Microbiol
Martínez SJ, Vanrell MC, Li X, Carrillo C, Engman DM, Romano PS.   +5 more
europepmc   +1 more source

A network-driven computational framework for identifying FDA-approved drug repurposing across heterogeneous brain cancers. [PDF]

Front Mol Biosci
Prakash O.
europepmc   +1 more source

US Food and Drug Administration Approval Summary: Eflornithine for High-Risk Neuroblastoma After Prior Multiagent, Multimodality Therapy. [PDF]

J Clin Oncol
Duke ES, Bradford D, Sinha AK, Mishra-Kalyani PS, Lerro CC, Rivera D, Wearne E, Miller CP, Leighton J, Sabit H, Zhao H, Lane A, Scepura B, Pazdur R, Singh H, Kluetz PG, Donoghue M, Drezner N.   +17 more
europepmc   +1 more source